BIOINVENT
BIOINVENT operates in Diversified Metals & Mining.
Market Cap & Net Worth: BIOINVENT (BIX)
BIOINVENT (BE:BIX) has a market capitalization of $25.71K (€25.05K) as of March 19, 2026. Listed on the BE stock exchange, this Germany-based company holds position #43321 globally and #6929 in its home market, demonstrating a 1.30% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BIOINVENT's stock price €2.73 by its total outstanding shares 9175 (9.18K).
BIOINVENT Market Cap History: 2015 to 2025
BIOINVENT's market capitalization history from 2015 to 2025. Data shows change from $3.51K to $25.71K (-8.21% CAGR).
BIOINVENT Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BIOINVENT's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
BIOINVENT's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $73.31K | $71.28 Million | -$62.59 Million | 0.00x | N/A |
| 2017 | $48.88K | $45.01 Million | -$100.53 Million | 0.00x | N/A |
| 2018 | $42.47K | $38.55 Million | -$123.16 Million | 0.00x | N/A |
| 2019 | $26.78K | $93.74 Million | -$138.63 Million | 0.00x | N/A |
| 2020 | $44.79K | $147.37 Million | -$76.33 Million | 0.00x | N/A |
| 2021 | $41.68K | $19.38 Million | -$278.44 Million | 0.00x | N/A |
| 2022 | $27.31K | $326.13 Million | -$42.50 Million | 0.00x | N/A |
| 2023 | $15.67K | $71.46 Million | -$330.30 Million | 0.00x | N/A |
Competitor Companies of BIX by Market Capitalization
Companies near BIOINVENT in the global market cap rankings as of March 19, 2026.
Key companies related to BIOINVENT by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
BIOINVENT Historical Marketcap From 2015 to 2025
Between 2015 and today, BIOINVENT's market cap moved from $3.51K to $ 25.71K, with a yearly change of -8.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €25.71K | -19.23% |
| 2024 | €31.83K | +103.12% |
| 2023 | €15.67K | -42.62% |
| 2022 | €27.31K | -34.48% |
| 2021 | €41.68K | -6.94% |
| 2020 | €44.79K | +67.28% |
| 2019 | €26.78K | -36.95% |
| 2018 | €42.47K | -13.11% |
| 2017 | €48.88K | -33.33% |
| 2016 | €73.31K | +1989.26% |
| 2015 | €3.51K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BIOINVENT was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.71K USD |
| MoneyControl | $25.71K USD |
| MarketWatch | $25.71K USD |
| marketcap.company | $25.71K USD |
| Reuters | $25.71K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.